MAP3K5 rs2076260: Genetic Variation and Longevity
The rs2076260 single-nucleotide polymorphism is a common genetic variant situated within the MAP3K5 gene, which encodes apoptosis signal-regulating kinase 1 (ASK1). Scientific studies have linked specific genotypes of this variant to extended lifespan and resilience against mortality, particularly among individuals managing chronic cardiometabolic diseases. However, evidence remains limited and heavily ancestry-dependent, meaning it serves as an indicator of statistical patterns rather than a direct predictor of individual healthspan.
What each genotype means
Common longevity-associated genotype
This is the major allele genotype for the rs2076260 variant. Research suggests that the association between this variant and lifespan may be context-dependent, specifically showing potential protective effects in men with pre-existing cardiometabolic disease, though these findings are limited and require further validation.
This is the most common genotype across most global populations.
Variant carrier genotype
You carry one copy of the minor allele. Studies have investigated whether this variant influences longevity through the MAP3K5 (ASK1) pathway, which regulates cellular stress responses, but the clinical significance remains uncertain and may be confined to specific health contexts.
Carried by a significant portion of the population, with minor allele frequencies typically ranging between 0.15 and 0.25 in European and East Asian cohorts.
Minor allele homozygote
You carry two copies of the minor allele. While this variant is studied for its potential role in modulating cellular stress responses and longevity, current evidence is limited and suggests that any impact on healthspan may be highly dependent on individual health status, such as the presence of cardiometabolic conditions.
This is the least common genotype, occurring at a frequency consistent with the minor allele distribution in the population.
Genetic Architecture: Where rs2076260 Sits
The single-nucleotide polymorphism rs2076260 is located within the human MAP3K5 gene on chromosome 6. At this genomic coordinate, the DNA sequence commonly carries either a cytosine (C) or a thymine (T) nucleotide. Although initially cataloged in some legacy repositories as a missense change, refined sequencing and transcript mapping confirm that the base substitution behaves functionally as a synonymous or non-coding intronic regulatory marker. Because of high linkage disequilibrium with neighboring variants such as rs6904753, rs2076260 serves as a tagging SNP. This means it reliably tracks a broader inherited genomic haplotype rather than necessarily altering protein structure on its own. Functional genomic datasets, such as the Genotype-Tissue Expression (GTEx) portal, indicate that variants in this linkage block correlate with expression quantitative trait loci (eQTLs) across vascular and metabolic tissues, including arterial and adipose tissue. As a consequence, inheriting particular alleles at rs2076260 may modulate transcription factor binding affinity or steady-state MAP3K5 transcript abundance.
The Biological Role of MAP3K5 (ASK1)
The MAP3K5 gene encodes mitogen-activated protein kinase kinase kinase 5, widely known as apoptosis signal-regulating kinase 1 (ASK1). As documented in the UniProt Knowledgebase, ASK1 is a critical serine/threonine kinase operating upstream in the p38 MAPK and JNK signaling pathways. Cells utilize ASK1 as a fundamental sensor for various forms of physiological stress, notably oxidative stress, endoplasmic reticulum (ER) stress, calcium overload, and inflammatory cytokines like tumor necrosis factor (TNF). Under resting conditions, ASK1 forms an inactive complex with regulatory proteins such as reduced thioredoxin. However, elevated reactive oxygen species (ROS) trigger ASK1 dissociation and activation, prompting mitochondria-dependent apoptosis or cell-cycle arrest. While controlled ASK1 signaling eliminates irreparably damaged cells, unchecked or chronic activation exacerbates systemic inflammation, endothelial dysfunction, and myocardial remodeling. Modulating ASK1 activity has consequently emerged as a key pharmacological target in cardiovascular, fibrotic, and metabolic medicine.
Current Longevity and Healthspan Research
Scientific evidence connecting rs2076260 to human lifespan remains limited and stems largely from longitudinal cohort analyses, particularly the Kuakini Honolulu Heart Program published in the journal Aging. In a long-term cohort of older American men of Japanese ancestry, researchers evaluated whether MAP3K5 variation influenced all-cause mortality over nearly three decades of follow-up. The investigators identified significant associations between the C allele—most notably in the CC homozygous state—and reduced mortality risk specifically among men diagnosed with baseline cardiometabolic diseases, such as coronary heart disease, hypertension, or type 2 diabetes. Intriguingly, this survival advantage was absent in individuals free of cardiometabolic conditions, suggesting an allele-dependent buffering mechanism that mitigates the physiological hazards of vascular stress. The same cohort also displayed survival patterns consistent with a heterozygote disadvantage model, where heterozygous individuals had slightly higher relative mortality than homozygotes. Because these findings have not been uniformly replicated across expansive multi-ancestry biobanks, overall evidence strength remains preliminary.
Population Frequency and Ancestral Distribution
Allele distributions for rs2076260 diverge substantially across global populations. Large-scale sequencing efforts, including the 1000 Genomes Project and the Genome Aggregation Database (gnomAD), show that the C allele has a frequency of approximately 50% to 55% in East Asian populations, making it the major allele in cohorts like Japanese and Han Chinese. Conversely, in European, African, and South Asian ancestral backgrounds, the C allele is much less frequent, occurring at minor allele frequencies typically between 15% and 25%. This notable difference in background frequency presents a statistical challenge for genome-wide association studies (GWAS) conducted primarily in European populations, where the relative rarity of CC homozygotes reduces statistical power to detect gene-by-environment interactions. Understanding these ancestry-specific baseline frequencies is essential when interpreting cohort-level data and prevents the misapplication of population-specific survival models to broader, genetically diverse populations.
What This Information Means for You
Discovering your rs2076260 genotype can provide fascinating insights into stress-response pathways, but it cannot be used as a standalone diagnostic tool or clinical prognosticator. Human longevity is an intensely polygenic and multifaceted trait, influenced by hundreds of subtle genetic variants working alongside diet, exercise, social factors, and access to medical care. Possessing a favorable longevity-associated genotype does not grant immunity from cardiovascular disease, nor does carrying an alternative genotype guarantee early mortality or poor health. Furthermore, because MAP3K5 influences metabolic signaling pathways, pharmaceutical researchers are investigating ASK1 inhibitors; however, genetic variants like rs2076260 are not clinical pharmacogenomic markers. Readers should never alter medication schedules, cardiovascular therapies, or lifestyle plans based on direct-to-consumer genetic findings. Any concerns regarding heart health, blood pressure management, or metabolic risks should always be discussed directly with a qualified healthcare professional.
How common is this variant?
The rs2076260 C allele is common in East Asian populations with a frequency around 50% to 55%, whereas in European and African cohorts it serves as the minor allele with frequencies ranging between 15% and 25%.
Frequently asked questions
Does having the rs2076260 CC genotype guarantee a long life?
No, having the CC genotype does not guarantee an extended lifespan. Human longevity is shaped by complex interactions between hundreds of genetic variants, environmental exposures, lifestyle habits, and routine healthcare. Statistical associations found in scientific research reflect subtle average population trends rather than a guaranteed personal outcome.
What is the MAP3K5 gene and why does it affect aging?
MAP3K5 produces the ASK1 enzyme, which regulates cellular responses to oxidative stress, endoplasmic reticulum stress, and inflammation. When cells experience chronic vascular or metabolic strain, ASK1 coordinates signaling cascades that determine whether a damaged cell survives or undergoes apoptosis. Variants in this gene may subtly alter stress resilience over decades.
Why do studies show different results across different ancestries?
The frequency of the rs2076260 alleles varies widely around the world, being far more common in East Asian populations than in European or African groups. In addition, because rs2076260 is a non-coding tagging variant, the specific functional regulatory variants it travels with can differ between ancestral lineages due to distinct patterns of linkage disequilibrium.
Can I use my rs2076260 result to guide medication or supplements?
No, rs2076260 is not recognized by clinical pharmacogenomics guidelines such as CPIC or PharmGKB for guiding medical treatments or drug doses. While research is exploring experimental drugs targeting the ASK1 pathway, you should never start, stop, or change any prescribed cardiovascular or diabetes medication without consulting your physician.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2076260?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29